Also interesting:
"A thorough review on PASS by the Company is nearing completion and will be released to the ASX as soon as possible".
We should find out what they are in the process of & what is happening with PASS.
From the 5B. They received $279k in Revenue ..."1.7 Research and development refunds $279k"
- Forums
- ASX - By Stock
- NAG
- Ann: Quarterly Report
Ann: Quarterly Report, page-3
Featured News
Add NAG (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $14.33M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.8¢ | $3.767K | 199.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 281224 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 293234 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 281224 | 0.018 |
3 | 321000 | 0.017 |
2 | 231250 | 0.016 |
8 | 798780 | 0.015 |
1 | 600000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 293234 | 1 |
0.020 | 100000 | 1 |
0.021 | 1675535 | 4 |
0.022 | 336000 | 3 |
0.023 | 696040 | 4 |
Last trade - 15.43pm 15/11/2024 (20 minute delay) ? |
Featured News
NAG (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online